Clinical trial
Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
NCT00335660 · Avera Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00335660 |
|---|---|
| Title | Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity |
| Official title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity |
| Lead sponsor | Avera Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Overactive Bladder Syndrome |
| Intervention type | Drug |
| Interventions | AV608 |
| Enrollment | 62 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jun 12, 2006 |
| Last update posted | Feb 25, 2008 |
| Countries | Netherlands, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: